The Primary Structure of the Inhibitor of Tissue Plasminogen Activator Found in the Seeds of Erythrina caffra

Summary

Trypsin and tissue plasminogen activator inhibitor DE-3 from Erythrina caffra contains 172 amino acids, including 4 half-cystine residues, and resembles the Kunitz-type inhibitors. Limited hydrolysis of DE-3 with trypsin at pH 3.2 produced two fragments, FI and F2, containing 63 and 109 amino acids, respectively. Amino-terminal sequence studies showed that FI was the N-terminal and that F2 was the C-terminal fragment. The complete amino acid sequence of the fragments were then determined on peptides produced by enzymatic digestion with trypsin. The sequence of trypsin and tissue plasminogen activator inhibitor DE-3 from E. caffra seeds shows a high degree of homology to that of trypsin and tissue plasminogen activator inhibitor DE-3 from E. latissima seeds and revealed only four amino acids which were replaced.

Keywords

Erythrina caffra - Trypsin and tissue plasminogen activator inhibitor - Amino acid sequence

• References

• 1 Kunitz M. Crystalline soybean trypsin inhibitor II. General properties. J Gen Physiol 1947; 30: 291-310
• 2 Kunitz M. Isolation of a crystalline protein compound of trypsin and of soybean trypsin-inhibitor. J Gen Physiol 1947; 30: 311-320
• 3 Yamamoto M, Hara S, Ikenaka T. Amino acid sequences of two trypsin inhibitors from Winged bean seeds (Psophocarpus tetragonolobus [L] DC). J Biochem 1983; 94: 849-863
• 4 Laskowski Jr M, Kato I. Protein inhibitors of proteinases. Ann Rev Biochem 1980; 49: 593-626
• 5 Joubert FJ, Carlsson F HH, Haylett T. Purification of two proteinase inhibitors (DE-1 and DE-3) from Erythrina latissima (Broad-leaved Erythrina) seed. Hoppe-Seyler’s Z Physiol Chem 1981; 362: 531-538
• 6 Joubert FJ, Heussen C, Dowdle E BD. The complete amino acid sequence of trypsin inhibitor DE-3 from Erythrina latissima seeds. J Biol Chem 1985; 260: 12948-12953
• 7 Koide T, Ikenaka T. Studies on soybean trypsin inhibitors. 1. Fragmentation of soybean trypsin inhibitor (Kunitz) by limited proteolysis and by chemical cleavage. Eur J Biochem 1973; 32: 401-407
• 8 Koide T, Ikenaka T. Studies on soybean trypsin inhibitors. 3. Amino acid sequence of the carboxy-terminal region and the complete sequence of soybean trypsin inhibitor (Kunitz). Eur J Biochem 1973; 32: 417-431
• 9 Koide T, Tsunasawa S, Ikenaka T. Studies on soybean trypsin inhibitors. 2. Amino acid sequence around the reactive site of soybean trypsin inhibitor (Kunitz). Eur J Biochem 1973; 32: 408-416
• 10 Heussen C, Joubert F, Dowdle E BD. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor. J Biol Chem 1984; 259: 11635-11638
• 11 Barneby RC, Krukoff BA, Raven PH. Erythrina Symposium. IV Erythrina (Fabaceae: Faboideae). Allertonia Pacific Tropical Botanical Garden, Lawai, Kauai, Hawaii 1982; 3: 154-165
• 12 Joubert FJ, Merrifield EH, Dowdle E BD. The reactive sites of proteinase inhibitors from Erythrina seeds. Int J Biochem. (submitted for publication)
• 13 Joubert FJ. Purification and properties of the proteinase inhibitors from Erythrina caffra (coast Erythrina) seed. Int J Biochem 1982; 14: 187-193
• 14 Brandt WF, Alk H, Chauhan Hauhan M, von Holt C. A simple modification converts the spinning cup protein sequencer into a vapour-phase sequencer. FEBS Lett 1984; 174: 228-232
• 15 Hewick RM, Hunkapiller MW, Hood LE, Dreyer WJ. A gas-liquid solid phase peptide and protein sequenator. J Biol Chem 1981; 256: 7990-7997
• 16 Wolfenden R, Andersson L, Cullis PM, Southgate C CB. Affinities of amino acid side chains for solvent water. Biochemistry 1981; 20: 849-855
• 17 Tanford C. The interpretation of hydrogen ion titration. Curves of patients. Adv Protein Chem 1962; 17: 69-165
• 18 Bergmann SR, Fox K AA, Ter-Pogossian MM, Sobel BE, Collen D. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science 1983; 220: 1181-1183
• 19 Van de Werf F, Bergmann SR, Fox K AA, De Geest H, Hoyng CF, Sobel BE, Collen D. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation 1984; 69: 605-610